Open Access

Dynamics of sterol synthesis during development of Leishmania spp. parasites to their virulent form

Parasites & Vectors20169:200

https://doi.org/10.1186/s13071-016-1470-0

Received: 4 December 2015

Accepted: 23 March 2016

Published: 12 April 2016

Abstract

Background

The Leishmania spp. protozoa, the causative agents of the “neglected” tropical disease leishmaniasis, are transmitted to mammals by sand fly vectors. Within the sand fly, parasites transform from amastigotes to procyclic promastigotes, followed by development of virulent (metacyclic) promastigote forms. The latter are infectious to mammalian hosts. Biochemical components localized in the parasite plasma membrane such as proteins and sterols play a pivotal role in Leishmania pathogenesis. Leishmania spp. lack the enzymes for cholesterol synthesis, and the dynamics of sterol acquisition and biosynthesis in parasite developmental stages are not understood. We hypothesized that dynamic changes in sterol composition during metacyclogenesis contribute to the virulence of metacyclic promastigotes.

Methods

Sterols were extracted from logarithmic phase or metacyclic promastigotes grown in liquid culture with or without cholesterol, and analyzed qualitatively and quantitatively by gas chromatograph-mass spectrometry (GC-MS). TriTrypDB was searched for identification of genes involved in Leishmania sterol biosynthetic pathways.

Results

In total nine sterols were identified. There were dynamic changes in sterols during promastigote metacyclogenesis. Cholesterol in the culture medium affected sterol composition in different parasite stages. There were qualitative and relative quantitative differences between the sterol content of virulent versus avirulent parasite strains. A tentative sterol biosynthetic pathway in Leishmania spp. promastigotes was identified.

Conclusions

Significant differences in sterol composition were observed between promastigote stages, and between parasites exposed to different extracellular cholesterol in the environment. These data lay the foundation for further investigating the role of sterols in the pathogenesis of Leishmania spp. infections.

Keywords

Leishmania Sterol Promastigotes Metacyclogenesis Virulence Sterol biosynthetic pathway

Background

Leishmania spp. are the etiological agents of leishmaniasis, a group of parasitic diseases that are endemic in 88 countries on four continents [1]. Over 20 Leishmania spp. are collectively responsible for varied clinic manifestations of human disease. Three major clinical forms include cutaneous leishmaniasis (CL), mucocutanous leishmaniasis and visceral leishmaniasis (VL). Data compiled by WHO show one million cases of CL in the last five years, and 300,000 cases of VL with 20,000 deaths annually (http://www.who.int/leishmaniasis/en/).

The Leishmania spp. protozoa alternate between a flagellated promastigote in the sand fly vector and an obligate intracellular amastigote, which lacks an external flagellum, in the mammalian host. After a sand fly vector takes a blood meal, amastigotes transform in the sand fly gut to procyclic promastigotes and several other intermediate stages, multiply by binary fission, and eventually develop to the metacyclic promastigotes which are infectious for mammalian hosts. Metacyclic promastigotes are inoculated by the sand fly vector during a blood meal into a new mammalian host [2]. This process of development from the procyclic to the metacyclic promastigotes is termed metacyclogenesis. Due to the technical challenges in raising sand flies in laboratory, metacyclogenesis is often modeled in liquid medium by culture of promastigotes in vitro from logarithmic to stationary growth phase, from which the metacyclic promastigotes can be isolated by density for some Leishmania spp. to more than 95 % purity [3]. Metacyclic promastigotes are morphologically distinguishable from procyclic cells by their elongated flagellum (at least double the cell body length), and their smaller body size.

Unlike mammalian cells but similar to fungi, Leishmania spp. are eukaryotic kinetoplastids that synthesize ergosterol [4]. They do not have the enzymes to synthesize cholesterol, although they have detectable cholesterol that they must take up from their external environment [5]. The sterols ergosterol or cholesterol are essential components of plasma membranes found in lipid rafts, membrane microdomains which are also classified as detergent resistant membranes (DRMs) due to their physicochemical properties [6, 7]. Our prior studies using the lipid-raft disrupting agent methyl-β-cyclodextrin (MβCD) suggested that lipid rafts play a pivotal role in the virulence of Leishmania spp. [8]. The anti-fungal agent amphotericin B is widely used in patients with leishmaniasis, especially in regions where parasites are resistant to standard therapy with antimony compounds [9, 10], or in patients co-infected with Leishmania sp. and human immunodeficiency virus (HIV) [11]. Amphotericin B preferentially binds to ergosterol, leading to disruption of the osmotic integrity of the membrane in target cells [12].

Given the association between sterol content and heat resistance of L. major [13], the objectives of current study were (i) to identify and quantify sterols in distinct stages of Leishmania infantum promastigotes that differ in their virulence for a mammalian host, and (ii) to determine the effects of cholesterol addition or depletion on promastigote sterol (particularly ergosterol) content. The data should provide a baseline for further study of drug- or environmentally-induced changes in parasite sterol content in the pathogenesis and control of Leishmania spp. infections.

Methods

Ethics Statement

The Animal Care and Use Committee of the Iowa City Veterans’ Affairs Medical Center reviewed and approved protocols for procedures used (Protocols number 1190301 and 1190302). The animal care and use were in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institute of Health.

Parasites

A Brazilian strain of Leishmania infantum (previously called L. chagasi) (MHOM/BR/00/1669) was serially passaged in golden hamsters to maintain parasite virulence. Amastigotes were isolated from infected hamster spleens and allowed to transform to promastigotes in HOMEM (Hemoflagellate modified Minimal Essential Medium) with 10 % fetal calf serum (FCS) and hemin made from commercially available ingredients as previously described [8]. Serum-free medium (SFM) was prepared similar to HOMEM but lacking FCS and with additional biopterin, adenosine and bovine serum albumin. Virulent promastigotes were used within three passages post-isolation from hamster. An avirulent strain L5 was derived from the same L. infantum isolate by serial passage in vitro for over five years as described [14].

Cultures of virulent or avirulent promastigotes were seeded at 1 × 106 cells/ml in HOMEM or SFM, and allowed to grow at 26 °C to the appropriate cell density, monitored daily by microscopic exam on a hemacytometer. Metacyclic promastigotes were isolated from Day 8 stationary-phase cultures of virulent strain parasites on a discontinuous Ficoll gradient as described [3]. Metacyclic promastigotes could not be recovered from similar cultures of avirulent promastigotes (data not shown). In some experiments, metacyclic promastigotes were incubated in 25 mM MβCD (Sigma, St. Louis, MO) freshly prepared in RPMI 1640 (GIBCO) at a cell density of 2 × 108 cells/ml at room temperature for 1 h to deplete cellular sterols, and then washed twice by centrifugation in Hanks’ balanced salt solution (GIBCO) as described [8, 15].

Sterol isolation from promastigotes

Sterols were extracted from logarithmic phase, stationary phase or metacyclic promastigotes with dicholoromethane and methanol (2:1 ratio [vol/vol]; Sigma) by sequential centrifugation according to a published protocol [16] with some modifications as previously described [8]. Dry sterol aliquots from 2 × 108 promastigote equivalents were maintained at -20 °C immediately after extraction until a single use. Extracted sterols were saponified in 30 % KOH in methanol and derivatized with dichloromethane and bis (trimethylsilyl) trifluroacetamide (BSTFA) (Sigma) in 1:2 ratio following a previously-described protocol [8].

Sterol identification

Dry derivatized trimethylsilyl derivatives were analyzed in the High Resolution Mass Spectrometry Facility at the University of Iowa using a ThermoFinnigan Voyager single quadruple mass spectrometer interfaced with a Trace2000 gas chromatograph (GC). The original software from the supplier was used for both data acquisition and processing. A DB-5ht capillary column (inner diameter, 0.25 mm; length 30 m) (JW Scientific Inc., Folsom, CA) was used. The GC temperature program settings were 175 °C for 1 min, ramp up at 10 °C/min to 280 °C, and hold at 280 °C for 30 min. The GC inlet temperature was set at 280 °C. The GC eluent was electronically ionized at 70 eV. The mass spectrometer was programmed to detect a mass range of 45–700 Da.

Sterol identification was achieved by two independent methods. First, the GC retention time of same chemical compound is very consistent under the same experimental conditions (GC column, solvent, temperature etc.). Therefore, known chromatograph grade cholesterol and ergosterol standards (Sigma) were used every time to generate spectra, used to identify the corresponding sterol in individual samples by comparison. For ergosterol-related compounds lacking appropriate standards, the GC retention time was used once identified (see below). Second, the unique mass spectrum of each GC peak was searched against the small-molecule library (2001 version) of the National Institute of Standards and Technology library (NIST)/EPA/NIH Mass Spectral Library, which was purchased with the GC-MS instrument. The library search program was integrated in the Xcalibur operating software. Positive identification of a sterol was made if its mass spectrum matched a sterol in the library with a SI/RSI matching factor score ≥780 at a probability score of at least 50.

Sterol quantification

Two approaches were used to quantify sterols, capable of either relative or absolute quantification. Multiple preliminary trials showed that either cholesterol or ergosterol amounts were proportionally and linearly correlated with the area under its respective sterol peak on GC spectra. Thus the area under peaks was used for relative quantification of sterol components. For each promastigote stage, the total amount of all sterols added up to 100 %.

The absolute amount of cholesterol was also quantified as follows. A standard curve was generated for each experiment using varying amounts of chromatograph-grade cholesterol that was deuterated at six positions ([2H]cholesterol; Sigma), and varying amounts of chromatograph-grade ergosterol (Sigma). Quality control for each experiment was achieved by comparing multiple standard curves run at the time of each experiment, requiring a correlation factor of 0.98 or higher between standard amounts and retention times/area under curves. Samples and standards that did not meet quality control were rerun. Known amounts of [2H] cholesterol were also spiked into each sample, and samples were analyzed at three levels of cell equivalents to make sure [2H] cholesterol from at least two cell equivalents were within the range of the standard curve. The absolute amount of unknown cholesterol in each sample was determined by its area relative to that of [2H] cholesterol standards. Amounts of ergosterol and other ergosterol-related sterols for which deuterated standards were not available were calculated considering their relative abundance compared to the absolute amount of cholesterol in the same sample. The peak areas under curves were used to generate the extrapolated values.

Sterol biosynthetic pathway (SBP) of Leishmania spp.

SBP genes of Trypanosoma cruzi have been identified in a recent publication [17]. Locus identifiers of T. cruzi SBP genes were used as gene ID to search TriTryp database (http://tritrypdb.org/tritrypdb/, latest access date 01/30/16), resulting in identification L. major homologues, which were used to pull out all Leishmania spp. genes. In case of failure, keywords of the current annotation of SBP genes of T. cruzi were used as gene text during search. Ergosta-7,22-dien-3β-ol was a unique case; keyword “ergosta” was used to search Kyoto Encyclopedia of Genes and Genomes (KEGG) website (http://www.genome.jp/kegg/, latest access date 01/30/16) to find KEGG reactions and enzymes. Afterwards, keyword “hydroxysteroid” was used to identify genes in TriTryp database. Three genes were identified in L. infantum, one of which was a conserved hypothetic protein. The protein sequence was used to BLAST and a putative hydroxy steroid dehydrogenase/isomerase was identified. Accession numbers for individual genes were identified by BLAST search.

Results

Sterol identification

We previously identified five sterols species from infectious L. infantum metacyclic promastigotes cultured in complete HOMEM in vitro [8]. The current investigations included logarithmic, stationary and metacyclic stage promastigotes in virulent (recent isolate) and avirulent L5 strains maintained in either HOMEM or SFM. All five of the previously identified sterols (cholesterol, two isomers of ergosterol with distinct GC retention time, ergosta-7,22-dien-3β-ol, and stigmasta-7,24(28)-dien-3β-ol) were identified in addition to four new sterols (ergostatetraenol, an additional isomer of ergosta-7,22-dien-3β-ol, zymosterol and lanosterol; Table 1; Fig. 1).
Table 1

Sterols identified by gas chromatograph-mass spectrometry (GC-MS) in promastigotes of Leishmania infantum derived from in vitro culture

Sterol

Identificationa

RRt b

Cholesterol

I

1.000

Zymosterol

New

1.030

Ergosterol - I

II

1.069

Ergosta-7,22-dien-3β-ol - I

New

1.078

Ergostatetraenol

New

1.086

Ergosterol - II

III

1.115

Ergosta-7,22-dien-3β-ol - II

VI

1.131

Lanosterol

New

1.157

Stigmasta-7,24(28)-dien-3β-ol

V

1.229

aI-V were identified previously [8]. New indicates sterols identified in the current study

bRelative retention time (RRt) to cholesterol on GC, which is the ratio of retention time of each sterol to that of cholesterol

Fig. 1

Representative gas chromatography spectra (GC) of total sterols of Leishmania infantum virulent and avirulent strains cultured in complete HOMEM or serum-free medium (SFM). Shaded peaks were identified as sterols with relative retention time to cholesterol as marked. 1.000-Cholesterol; 1.030-Zymosterol; 1.069-Ergosterol – I; 1.078-Ergosta-7,22-dien-3β-ol – I; 1.086-Ergostatetraenol; 1.115-Ergosterol – II; 1.131-Ergosta-7,22-dien-3β-ol – II; 1.157-Lanosterol; and 1.229-Stigmasta-7,24(28)-dien-3β-ol. a Stationary promastigotes of virulent strain cultured in HOMEM. b Stationary promastigotes of avirulent L5 strain cultured in HOMEM. c Stationary promastigotes of virulent strain cultured in SFM. The GC spectra of metacyclic promastigotes had been previously published [8]

Dynamic changes in sterols during promastigote metacyclogenesis

Discovery of sterols that are differentially represented in metacyclic versus less virulent promastigotes may provide clues to the differentiation and pathogenicity of the metacyclic promastigotes. Therefore sterols were isolated from a recent isolate of virulent L. infantum promastigotes cultured in HOMEM with 10 % FCS in vitro, in either logarithmic (day 3 to 4 of culture) or metacyclic stage. Metacyclic promastigotes were isolated from day 8 stationary-phase promastigotes.

The dominant sterols in logarithmic-phase promastigotes were ergosterols. Ergosterol-I and ergosterol-II, two isomers with distinct retention times on the GC column, accounted for 30.92 % and 39.13 % of total sterols, respectively (Fig. 2a). The third most abundant sterol was cholesterol, accounting for 14.60 % of total sterols. In contrast, in stationary-phase promastigotes the two ergosterol isomers accounted for only 19.09 % and 21.74 %, respectively of total sterols, whereas cholesterol was the most abundant and constituted 27.77 % of total sterols (Fig. 2a). Metacyclic promastigotes were different from both; the two ergosterols accounted for only 8.94 % and 5.18 %, respectively, of total metacyclic promastigotes sterols. The two most abundant sterols in metacyclics were ergosta-7,22-dien--3β-ol-II and cholesterol, accounting for 37.90 % and 29.11 % of total sterols, respectively. The differences in sterols among the various promastigote stages were statistically significant (Fig. 2a), suggesting a stage-specific expression of various sterols in virulent L. infantum promastigotes.
Fig. 2

Sterol amount in percentage (%) among logarithmic, stationary and metacyclic promastigotes of L. infantum virulent or avirulent L5 strain grown in complete HOMEM or serum-free medium (SFM). LOG: logarithmic phase promastigotes; STAT: stationary phase promastigotes; META: metacyclic promastigotes. For each developmental stage, all sterols were added up to 100 %. a Virulent strain grown in HOMEM. b Avirulent L5 strain grown in HOMEM or SFM. c Stationary phase promastigotes of virulent strain cultured in HOMEM or SFM. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001

We also analyzed sterols of a L. infantum avirulent L5 strain, which was derived by continuous culturing in vitro of a wild-type virulent strain for over 5 years as previously described [14]. As previously shown L5 appeared to undergo no metacyclogenesis, since almost no metacyclic promastigotes were recovered from stationary-phase L5 promastigotes (< 0.1 % recovery rate, compared to 13.4 % in the wild-type strain) [3]. In this strain, the most abundant sterols in both log and stationary phase promastigotes were ergosterol-II, accounting for 39.93 % and 39.28 % of total sterols, respectively (Fig. 2b). In log phase promastigotes the next two most abundant sterols were ergosterol-I (28.68 %) and cholesterol (16.68 %). In stationary cells, they were cholesterol (33.69 %) and ergosterol-I (18.99 %) (Fig. 2b). The difference between these two stages were statistically significant (Fig. 2b), indicating there is stage-specific variation in sterols in avirulent L. infantum, even in the absence of the capacity to undergo metacyclogenesis.

Cholesterol in the culture medium affected sterol composition in L. infantum promastigotes

Trypanosomatid protozoa do not have the enzymes to synthesize cholesterol, and it has been shown that the bloodstream form of T. brucei can take up cholesterol from its environment [4]. As such, we hypothesized that the Leishmania culture medium might be an important determinant of the protozoan sterol composition. Promastigotes were cultured in parallel in either HOMEM supplemented with 10 % FCS, thus bathing the parasites in an exogenous source of cholesterol, or in a defined SFM that was similar to HOMEM but lacked serum (and thus lacked cholesterol). Sterols from stationary growth-phase promastigotes incubated in these media were compared. In virulent strain L. infantum, cholesterol accounted for 27.77 % and 3.69 % of total sterols in parasites grown in the serum-containing or serum-free media, respectively (P < 0.001, Fig. 2c). The proportions were 33.69 % and 1.14 % in avirulent L5 strain L. infantum, respectively (P < 0.0001, Fig. 2b). These data verified that cholesterol was reduced to minimal amounts in promastigotes incubated in a cholesterol-low environment, while other compounds were not as dramatically altered. Whether these were compensatory changes or merely changes in proportions required us to study the absolute cholesterol amounts, below.

Sterols in virulent versus avirulent strain of L. infantum

Qualitative and quantitative differences in sterol composition between virulent and avirulent Leishmania spp. have not been reported, nor has it been determined whether virulence affects the ability of promastigotes to adsorb cholesterol from their environment. We therefore compared the relative amounts of each sterol component in log or stationary phase virulent or avirulent strains of L. infantum, cultured in either cholesterol-containing HOMEM or in cholesterol-free SFM. The results are summarized in Table 2. Several differences were observed. First, both virulent and avirulent L. infantum were able to adsorb cholesterol from the environment. Second, the amount of ergosterol-I in virulent L. infantum grown in SFM was proportionally greater than the avirulent L5 strain, with the difference made up by a relative decrease in ergosterol-II. Ergosterol-II was also decreased in virulent stationary parasites incubated in HOMEM, but in this case it was compensated by a significant increase in ergosta-7,22-dien-3β-ol compared to the avirulent L5 strain in either log or stationary growth phase (Table 2). These data demonstrate a difference in sterol synthesis between virulent and avirulent strains that extends beyond the ability to adsorb cholesterol from the external environment.
Table 2

Relative sterol content of a recently isolated virulent (vir) strain compared to an avirulent (L5) strain of Leishmania infantum

Parasite-growth phase

L5-LOG (n = 2)

Vir-LOG (n = 3)

L5-STAT (n = 5)

Vir-STAT (n = 11)

L5-STAT (n = 3)

Vir-STAT (n = 3)

Growth Medium

HOMEM

SFM

Sterol:

      

Cholesterol

16.68 (3.70)

14.60 (0.38)

33.69 (5.25)

27.77 (7.94)

1.14 (0.13)

3.69 (4.28)

Zymosterol

0.00 (0.00)

0.00 (0.00)

0.27 (0.38)

0.71 (2.17)

0.72 (0.63)

2.52 (2.25)

Ergosterol -I

28.68 (6.48)

30.92 (3.73)

18.99 (3.85)

19.09 (7.59)

22.96 (3.09)

34.70* (5.98)

Ergosta-7,22-dien-3β-ol - I

5.62 (6.48)

4.76 (3.74)

2.29 (1.58)

5.50 (4.64)

2.16 (1.94)

1.64 (1.33)

Ergostatetraenol

3.27 (4.62)

3.38 (3.57)

1.92 (1.72)

0.72 (1.25)

1.97 (1.80)

3.39 (2.39)

Ergosterol -II

39.93 (2.62)

39.13 (1.37)

39.28 (5.81)

21.74** (11.33)

50.17 (5.33)

31.33* (8.09)

Ergosta-7,22-dien-3β-ol- II

1.71 (0.04)

6.58* (1.20)

0.84 (0.66)

20.66*** (9.43)

12.69 (9.50)

12.56 (7.28)

Lanosterol

0.00 (0.00)

0.00 (0.00)

0.16 (0.36)

0.15 (0.35)

1.14 (1.07)

0.58 (1.00)

Stigmasta-7,24(28)-dien-3β-ol

4.10 (5.80)

0.63 (0.32)

2.50 (3.44)

3.65 (1.88)

4.77 (2.50)

9.60 (5.17)

Data show the average (standard deviation) percentages of each sterol relative to the total amount of sterols in each cell type, set at 100 %. Sterols were identified and quantified by gas chromatograph-mass spectrometry. L. infantum virulent (vir) or avirulent L5 promastigotes were cultured in either HOMEM or serum free medium (SFM) and harvested for sterol analyses in logarithmic (LOG) or stationary (STAT) growth phases

*P < 0.05; **P < 0.01; ***P < 0.001

Dynamic changes in absolute amounts of sterols during promastigote metacyclogenesis

The above proportional differences in sterol content cannot reveal whether some parasite forms are relatively depleted of membrane sterols. We therefore measured absolute sterol amounts either directly or indirectly as described above. Surprisingly, stationary-phase promastigotes cultured in HOMEM had roughly two times the total sterol content compared to purified metacyclic promastigotes. The most dramatic differences were in cholesterol, and ergosterol-I and -II (Table 3). Depletion of sterols in the metacyclic promastigotes by MβCD treatment validated the measurements of sterols in other forms.
Table 3

Absolute amounts of sterols of stationary and metacyclic promastigotes of a virulent strain of Leishmania infantum, incubated in the absence or presence of MβCDa

Sterol

Stationary (n = 6)

Metacyclic (n = 6)

MβCD-metacyclic (n = 6)

Cholesterol

448.3 (249.2)

248.9 (120.8)

89.0 (40.6)*

Ergosterol -I

331.0 (290.5)

68.4 (13.1)

40.3 (22.3)*

Zymosterol

44.2 (108.2)

0.0 (0.0)

0.0 (0.0)

Ergosta-7,22-dien-3β-ol - I

81.8 (40.6)

100.6 (45.8)

49.3 (17.2)*

Ergostatetraenol

0.0 (0.0)

0.0 (0.0)

0.0 (0.0)

Ergosterol - II

403.6 (437.7)

35.7 (33.4)

11.5 (9.3)

Ergosta-7,22-dien-3β-ol - II

387.8 (282.1)

318.9 (137.8)

81.8 (37.3)**

Lanosterol

6.4 (15.7)

0.0 (0.0)

0.0 (0.0)

Stigmasta-7,24(28)-dien-3β-ol

62.8 (63.6)

37.8 (19.4)

17.5 (8.6)*

Total

1766.0 (1307.8)

810.2 (239.2)

289.5 (120.7)**

aNumbers indicate the mean (SD) absolute concentrations of sterols (ng/107 cells). Metacyclic promastigotes were isolated from stationary phase promastigotes as previously described [3]. An aliquot of the metacyclic cells were treated with 25 mM MβCD

*P < 0.05; **P < 0.01 between metacyclic and MβCD-treated metacyclic promastigotes

Absolute sterol content in avirulent or virulent parasites in different culture media

Absolute quantification revealed that total sterols were higher in either virulent or avirulent L. infantum strains when cultured in a cholesterol-containing medium (HOMEM) than in medium without cholesterol (SFM). Furthermore, virulent parasites contained more total sterols than the avirulent L5 strain grown in either medium. In virulent strain L. infantum promastigotes, the amount of cholesterol in stationary phase promastigotes was about 25 times higher when cultured in HOMEM (448.3 ng) than in SFM (18.0 ng). Nevertheless the cells in SFM synthesized more ergosterol-I and -II, i.e., 1001.8 ng in SFM compared to 734.6 ng in the HOMEM (Additional file 1: Table S1). In avirulent L5 strain L. infantum, the cholesterol amount was also many-fold higher when promastigotes were cultured in HOMEM than in SFM. Interestingly and in contrast to the virulent strain, L5 promastigotes in SFM appeared not to have synthesized more ergosterols despite cholesterol depletion (Additional file 1: Table S1).

Leishmania spp. sterol biosynthetic pathway (SBP)

Based on the Trypanosoma cruzi genome, homologous SBP genes of L. infantum were identified for the multiple reactions from farnesyl diphosphate to ergosterol. Furthermore, an enzyme was identified for the reaction between ergosterol and ergosta-7,22-dien-3β-ol. Consequently all identified sterols reported in the current study were fitted in an SBP as shown in Fig. 3. One exception was stigmasta-7,24(28)-dien-3β-ol. No entry was found in either the TriTryp or the KEGG databases using keyword “stigmasta”. Corresponding genes and accession numbers of other Leishmania spp., including but are not limited to L. donovani, L. major, L. braziliensis, L. mexicana and L. panamensis, were also identified (Additional file 2: Table S2).
Fig. 3

Sterol biosynthetic pathway of Leishmania spp. Sterols identified in the current study are labeled in red. Enzymes involved in each step of reaction are: 1, Lanosterol 14-α-demethylase; 2, C-14 sterol reductase; 3, C-5 sterol desaturase; 4, NAD(p)-dependent steroid dehydrogenase-like protein; 5 & 6, unknown; 7, Sterol 24-c-methyltransferase; 8, C-8 sterol isomerase-like protein; 9, Lathosterol oxidase-like protein; 10, Cytochrome p450-like protein; 11, Sterol C-24 reductase; 12, Hydroxysteroid dehydrogenase/isomerase

Discussion

The genomes of the trypanosomatid protozoans, including Trypanosoma spp. and Leishmania spp., have genes encoding enzymes that catalyze the biosynthesis of ergosterol but not cholesterol [1821]. This characteristic is more similar to fungi than other eukaryotes including mammals [22]. Consequently, amphotericin B, which selectively binds to ergosterol leading to disruption of the osmotic integrity of the membrane in target cells [12], is a powerful agent used for treatment of leishmaniasis and fungal infections of medical and veterinary importance. Amphotericin B is widely used as a first-line anti-leishmanial agent in patients from India where antimony-resistant strains of Leishmania spp. are the rule, or in the case of HIV - Leishmania spp. co-infections [10, 23].

Goad and colleagues (1984) identified major sterols of promastigotes of L. tropica, L. donovani, L. mexicana and L. major by GC-MS[5], and Xu and colleagues recently quantified sterols of L. major [13]. In keeping with the efficacy of treatment modalities, transient treatment with miltefosine, the first orally active anti-leishmanial drug effective in VL, significantly affects sterol content of L. donovani promastigotes. In one study, cholesterol and cholesta-5,7,24-trien-3β-ol were 2× and 32× higher, respectively, whereas ergosta-7,24(28)-dien-3β-ol and ergosta-5,7,24(28)-trien-3β-ol were 15× and 5 × lower, respectively, in miltefosine treated than untreated promastigotes [24]. Similarly, other anti-leishmanial agents such as chalcone and azasterols changed sterol profiles in L. amazonensis [25, 26]. Drug resistance is associated with significantly altered sterol profiles (e.g. atovaquone-resistant L. infantum [16], miltefosine-resistant L. donovani [27]).

Despite their inability to synthesize the compound, Trypanosomatids have ample cholesterol when measured [28], leading to questions about the relative importance of different sterols in pathogenesis. Herein we describe qualitative and quantitative analyses of sterol content in L. infantum promastigotes, the causative agent of VL. Our data suggest there is substantial adsorption of cholesterol from the parasite’s external environment, complicating interpretation of sterol content. To the best of our knowledge, this is the first report of the absolute amounts of sterols in parasites that differ in virulence and in developmental stage. We also make the unique observation that the sterol content is dramatically altered in different environmental media.

Sterols are identified by their relative retention time (RRt) observing their mass spectrum peak on gas chromatography. Goad and colleagues (1984) measured sterols in logarithmic-phase promastigotes of several Leishmania spp., reporting only trace amounts of cholesterol in cells cultured in lipid-free medium [5]. Ergosta-5,7,24(28)-trien-3β-ol was the dominant sterol among various species of Leishmania spp., ranging from about 60 % in L. major, 70 % in L. tropica, L. mexicana and L. donovani and up to 90 % in L. amazonensis and L. pifanoi [5]. Consistent with that report, we observed that cholesterol comprised less than 4 % of total sterols in promastigotes cultured in cholesterol-free SFM, with a much higher representation of ergosterol. This was in contrast to much higher percentages of cholesterol in promastigotes cultured in HOMEM containing FCS as a cholesterol source, confirming the ability of parasites in either growth stage to adsorb cholesterol from their external medium. In addition we detected eight sterols other than cholesterol, all presumptively precursors or derivatives of ergosterol (Fig. 3) (discussed below). These observations are consistent with the conclusion that ergosterol is the major sterol synthesized by Leishmania spp. with or without cholesterol in the external environment.

Less abundant sterols included ergosta-7,22-dien-3β-ol (20.7 %), stigmasta-7-24(28)-dien-3β-ol, ergostatetraenol, zymosterol and lanosterol, all less than 4 %. The last three had been found to be precursors of ergosterol in Leishmania spp., T. brucei, T. cruzi and the yeast Saccharomyces cerevisiae [4, 17, 29, 30]. Ergosta-7,22-dien-3β-ol has been previously detected in L. donovani and L. amazonensis [24, 26, 27] as well as in S. cerevisiae yeast and Ganoderma pfeifferi fungus [31, 32]. How it fits to the SBP has not been established. We identified an enzyme, hydroxysteroid dehydrogenase/isomerase (Accession number: XP_001464825.1) in the Leishmania genome, which could potentially catalyze a reaction linking ergosta-7,22-dien-3β-ol to ergosterol (Fig. 3). Stigmasta-7–24(28)-dien-3β-ol has been found in the fungus Gymnosporangium juniper [33]; ergostatetraenol in Candida albicans and S. cerevisiae [34, 35]; ianosterol in the woody plant pathogen Eutypa lata [36]; and zymosterol in S. cerevisiae [35].

Further discussion of stigmasta-7–24(28)-dien-3β-ol is warranted. This sterol has not been found in T. brucei [29] although it is often found in fungi and plants. This observation might have several explanations. First, the validity of stigmasta-7–24(28)-dien-3β-ol identification must be considered. The GC-MS peaks favorably argues for its identification, which is shown in the Additional file 3: Fig. S1. Secondly, this sterol might be taken up by Leishmania spp. promastigote from FCS, where it could be present in trace amounts. Our data do not support such a scenario. As showed in Table 2 promastigotes cultured in SFM had higher levels of this sterol compared to the cells derived from HOMEM. Thirdly, biosynthetic enzymes for this sterol might be unique to Leishmania spp. Stigmastanol is formed from either β-sitosterol by reduction, or through hydrogenation of stigmasterol.

Stigmasterol and sitosterol are phytosterols derived from mevalonate biosynthetic pathways. Isoprenoid synthesis is controlled by 3-hydroxy-3-methylglutaryl-CoA reductase (HMG-CoA reductase). The first committed step toward phytosterol biosynthesis is SMT1 (C-24 sterol methyl transferase), and the subsequent action of SMT2, which catalyzes a methyl transfer to methylene lophenol, directs the product toward sitosterol and stigmasterol biosynthesis. The annotated genomes of both L. infantum and T. brucei include genes predicted to encode a HMG-CoA reductase (LinJ.30.3230 and Tb927.6.4540). Two genes for a sterol 24-C methyl transferase are found in the L. infantum JPCM5 genome: LinJ.36.2510 and LinJ.36.2520, as is a sterol C-24 reductase (LinJ.33.0730) and several other (C-8, C-14) sterol reductases. The T. brucei genome also encodes two sterol 24-C-methyl transferases (TB11.v5.0496, Tb927.10.6950) and only one annotated (C-14) sterol reductase. Whether the enzymes of L. infantum participate in stigmastanol synthesis, and whether the additional sterol reductase genes present in L. infantum over T. brucei are influential in the differential recognition of stigmastanol only in L. infantum, cannot be determined without further experimental evidence. ([37], trytrypdb.org).

This would not be the first discovery of a pathway in Leishmania spp. that is more closely related to fungal metabolic pathways than those of Trypanosoma brucei. Indeed, T. brucei take in iron primarily through a transferrin receptor, whereas the Leishmania species use a two-step surface ferric iron reductase (Fe3+ → Fe2+)/ferrous iron transferase [3840].

Calculations of absolute amounts of each sterol allowed us to assess (1) whether the total sterol content is associated with parasite virulence, and (2) whether adsorbed cholesterol inhibits ergosterol synthesis. Relevant to the first question, the total amount of sterols in 1 × 107 stationary-phase promastigotes was 1,766.0 ng, roughly double the amount in purified metacyclic promastigotes from the same culture (810.2 ng, Table 3). The difference was mainly accounted for by a reduction in ergosterol I and II, with a lowering of adsorbed cholesterol as a second contributory change. L. infantum stationary-phase promastigotes contain 41.4 % metacyclic cells [3], so the remaining non-metacyclic promastigotes must have accounted for the differences. This difference may be partially explained by a smaller body size of the metacyclic promastigotes observed in both flow cytometry [41, 42] and microscopy [3, 41, 4346], although this cannot be the full explanation since there were proportional differences between sterols in the populations, and because most sterols are located at the cellular membrane [47, 48]. Nevertheless, the significant difference in proportions suggest differences in ergosterol synthesis may contribute. Metabolic changes during metacyclogenesis could in part be favored by the absence of purine, or by an acidic environment [4951]. It is possible that other environmental conditions such as environmental cholesterol/sterol concentrations also favor metacyclogenesis.

Cholesterol and ergosterol are integral components of plasma membrane micro-domains called lipid rafts, also known as detergent-resistant membrane (DRMs) [52]. MβCD specifically chelates and depletes sterols from lipid rafts. In the current study we confirmed our earlier report that MβCD treatment of metacyclic promastigotes reduced the total amount of cellular sterols by two thirds. We previously reported that lipid-raft depleted metacyclic promastigotes exhibit increased sensitivity to complement medicated lysis in vitro and reduced infectivity for mice in vivo [8].

Leishmania spp. are inoculated by the sand fly into mammalian tissue in a pool of blood, a relatively cholesterol rich environment. Our observations raise the possibility that suspension in such an environment might alter the membrane sterol content of the inoculated parasite. Host cholesterol levels affect the outcomes of Leishmania spp. infections. It has been reported that high circulating lipid levels offer protection against L. donovani infection in a mouse model where mice were either provided a high-cholesterol (atherogenic) diet or underwent statin treatment [53]. Similarly, patients with active VL had a lower level of total cholesterols during acute disease than four months after VL resolution in the same patients, and lower cholesterol than healthy volunteer controls [54]. Whether transient exposure to this environment at the initial stage of infection affects the virulence of promastigotes is a matter of speculation. From the current work we can conclude that the sterol content of Leishmania promastigotes is dynamic and responds not only to environmental conditions, but also the developmental changes that occur during metacyclogenesis. These changes seem to be a result of both adsorption of cholesterol from the environment, and likely also ergosterol synthesis by the Leishmania spp. parasites. The interaction between sterol content and parasite virulence is a yet evolving story.

Conclusions

Leishmaniasis causes 20,000 annual deaths and is a threat to 5 % of the populations of four continents worldwide. Its causative pathogens include more than 20 species of protozoan parasites in the genus of Leishmania, and there is an association between parasite species and clinical outcomes. The pathogenic mechanisms used by the parasite are incompletely understood, and a better understanding could speed both vaccine development and new drug discovery. We hypothesized that dynamic changes in sterol composition during parasite development contribute to development of virulent forms of the parasite that are the most infectious for mammalian hosts such as humans. Qualitative and quantitative measures of sterols using gas chromatograph-mass spectrometry enabled us to contrast sterols in infectious versus non-infectious parasite forms. Our data clearly showed a unique profile of sterols in the infectious parasites, and revealed that external environment is a major determinate of cellular sterol content. These discoveries warrant further investigation of roles of sterols in Leishmania spp. pathogenesis.

Abbreviations

CL: 

cutaneous leishmaniasis

DRM: 

detergent resistant membranes

FCS: 

fetal calf serum

GC-MS: 

gas chromatograph-mass spectrometry

KEGG: 

Kyoto Encyclopedia of Genes and Genomes

MβCD: 

methyl-β-cyclodextrin

SFM: 

serum free medium

RRt: 

relative retention time

VL: 

visceral leishmaniasis.

Declarations

Acknowledgment

The authors are very grateful to Dr. Lynn M. Teesch of High Resolution Mass Spectrometry Facility, University of Iowa for her help in analyzing sterols by GC-MS. The cost of publication is paid by an intramural grant of One Health Center for Zoonoses and Tropical Veterinary Medicine of Ross University School of Veterinary Medicine. The work was funded in part by NIH grants R01 AI076233 and R01 AI045540, and Merit Review grants 5I01BX001983 and 2I01BX000536 from the Department of Veterans’ Affairs.

COPYRIGHT NOTICE. The article is a work of the United States Government; Title 17 U.S.C 105 provides that copyright protection is not available for any work of the United States government in the United States. Additionally, this is an open access article distributed under the terms of the Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0), which permits worldwide unrestricted use, distribution, and reproduction in any medium for any lawful purpose.

Authors’ Affiliations

(1)
Department of Biomedical Sciences and One Health Center for Zoonoses and Tropical Veterinary Medicine, Ross University School of Veterinary Medicine
(2)
Departments of Internal Medicine, Microbiology and Epidemiology, University of Iowa
(3)
Iowa City VA Medical Center

References

  1. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27(5):305–18.View ArticlePubMedGoogle Scholar
  2. Bates PA. Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies. Int J Parasitol. 2007;37(10):1097–106.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Yao C, Chen Y, Sudan B, Donelson JE, Wilson ME. Leishmania chagasi: Homogenous metacyclic promastigotes isolated by buoyant density are highly virulent in a mouse model. Exp Parasitol. 2008;118:129–33.View ArticlePubMedGoogle Scholar
  4. Roberts CW, McLeod R, Rice DW, Ginger M, Chance ML, Goad LJ. Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa. Mol Biochem Parasitol. 2003;126(2):129–42.View ArticlePubMedGoogle Scholar
  5. Goad LJ, Holz JGG, Beach DH. Sterols of Leishmania species, implications for biosynthesis. Molecular & Biochemical Parasitology. 1984;10:161–70.View ArticleGoogle Scholar
  6. Denny PW, Field MC, Smith DF. GPI-anchored proteins and glycoconjugates segregate into lipid rafts in Kinetoplastida. FEBS Lett. 2001;491(1-2):148–53.View ArticlePubMedGoogle Scholar
  7. Denny PW, Goulding D, Ferguson MA, Smith DF. Sphingolipid-free Leishmania are defective in membrane trafficking, differentiation and infectivity. Mol Microbiol. 2004;52(2):313–27.View ArticlePubMedGoogle Scholar
  8. Yao C, Gaur Dixit U, Barker JH, Teesch LM, Love-Homan L, Donelson JE, Wilson ME. Attenuation of Leishmania infantum chagasi metacyclic promastigotes by sterol depletion. Infect Immun. 2013;81(7):2507–17.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Mishra BB, Kale RR, Singh RK, Tiwari VK. Alkaloids: Future prospective to combat leishmaniasis. Fitoterapia. 2009;80(2):81–90.View ArticlePubMedGoogle Scholar
  10. Sundar S. Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health. 2001;6(11):849–54.View ArticlePubMedGoogle Scholar
  11. Durand R, Paul M, Pratlong F, Rivollet D, Dubreuil-Lemaire ML, Houin R, Astier A, Deniau M. Leishmania infantum: lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis. Antimicrob Agents Chemother. 1998;42(8):2141–3.PubMedPubMed CentralGoogle Scholar
  12. Ellis D. Amphotericin B: spectrum and resistance. J Antimicrob Chemother. 2002;49 Suppl 1:7–10.View ArticlePubMedGoogle Scholar
  13. Xu W, Hsu FF, Baykal E, Huang J, Zhang K. Sterol biosynthesis is required for heat resistance but not extracellular survival in Leishmania. PLoS Pathog. 2014;10(10):e1004427.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Roberts SC, Wilson ME, Donelson JE. Developmentally regulated expression of a novel 59-kDa product of the major surface protease (Msp or gp63) gene family of Leishmania chagasi. J Biol Chem. 1995;270(15):8884–92.View ArticlePubMedGoogle Scholar
  15. Yao C, Donelson JE, Wilson ME. Internal and surface-localized MSP of Leishmania and their differential release from promastigotes. Eukaryot Cell. 2007;6(10):1905–12.View ArticlePubMedPubMed CentralGoogle Scholar
  16. Cauchetier E, Loiseau PM, Lehman J, Rivollet D, Fleury J, Astier A, Deniau M, Paul M. Characterisation of atovaquone resistance in Leishmania infantum promastigotes. Int J Parasitol. 2002;32(8):1043–51.View ArticlePubMedGoogle Scholar
  17. Cosentino RO, Aguero F. Genetic profiling of the isoprenoid and sterol biosynthesis pathway genes of Trypanosoma cruzi. PLoS One. 2014;9(5):e96762.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Berriman M, Ghedin E, Hertz-Fowler C, Blandin G, Renauld H, Bartholomeu DC, Lennard NJ, Caler E, Hamlin NE, Haas B Lennard NJ, Caler E, Hamlin NE, Haas B et al. The genome of the African trypanosome Trypanosoma brucei. Science. 2005;309(5733):416–22.Google Scholar
  19. El-Sayed NM, Myler PJ, Bartholomeu DC, Nilsson D, Aggarwal G, Tran AN, Ghedin E, Worthey EA, Delcher AL, Blandin G et al. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science. 2005;309(5733):409–15.View ArticlePubMedGoogle Scholar
  20. El-Sayed NM, Myler PJ, Blandin G, Berriman M, Crabtree J, Aggarwal G, Caler E, Renauld H, Worthey EA, Hertz-Fowler C et al. Comparative genomics of trypanosomatid parasitic protozoa. Science. 2005;309(5733):404–9.View ArticlePubMedGoogle Scholar
  21. Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, Berriman M, Sisk E, Rajandream MA, Adlem E, Aert R et al. The genome of the kinetoplastid parasite, Leishmania major. Science. 2005;309(5733):436–42.View ArticlePubMedPubMed CentralGoogle Scholar
  22. McCall L-I, El Aroussi A, Choi JY, Vieira DF, De Muylder G, Johnston JB, Chen S, Kellar D, Siqueira-Neto JL, Roush WR et al. Targeting ergosterol biosynthesis in Leishmania donovani: essentiality of sterol 14alpha-demethylase. PLoS Negl Tropic Dis. 2015;9(3):e0003588.View ArticleGoogle Scholar
  23. Cota GF, de Sousa MR, de Mendonca AL, Patrocinio A, Assuncao LS, de Faria SR, Rabello A. Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil. PLoS Negl Tropic Dis. 2014;8(4):e2816.View ArticleGoogle Scholar
  24. Rakotomanga M, Blanc S, Gaudin K, Chaminade P, Loiseau PM. Miltefosine affects lipid metabolism in Leishmania donovani promastigotes. Antimicrob Agents Chemother. 2007;51(4):1425–30.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Lorente SO, Rodrigues JC, Jimenez Jimenez C, Joyce-Menekse M, Rodrigues C, Croft SL, Yardley V, de Luca-Fradley K, Ruiz-Perez LM, Urbina J et al. Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis. Antimicrob Agents Chemother. 2004;48(8):2937–50.View ArticlePubMedPubMed CentralGoogle Scholar
  26. Torres-Santos EC, Sampaio-Santos MI, Buckner FS, Yokoyama K, Gelb M, Urbina JA, Urbina JA, Rossi-Bergmann B. Altered sterol profile induced in Leishmania amazonensis by a natural dihydroxymethoxylated chalcone. J Antimicrob Chemother. 2009;63(3):469–72.Google Scholar
  27. Rakotomanga M, Saint-Pierre-Chazalet M, Loiseau PM. Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions. Antimicrob Agents Chemother. 2005;49(7):2677–86.View ArticlePubMedPubMed CentralGoogle Scholar
  28. de Souza W, Rodrigues JC. Sterol biosynthesis pathway as target for anti-trypanosomatid drugs. Interdiscip Perspect Infect Dis. 2009;2009:642502.PubMedPubMed CentralGoogle Scholar
  29. Nes Craigen R, Singha Ujjal K, Liu J, Ganapathy K, Villalta F, Waterman Michael R, Lepesheva Galina I, Chaudhuri M, Nes WD. Novel sterol metabolic network of Trypanosoma brucei procyclic and bloodstream forms. Biochem J. 2012;443(1):267–77.View ArticlePubMedPubMed CentralGoogle Scholar
  30. Oehlschlager AC, Angus RH, Pierce AM, Pierce Jr HD, Srinivasan R. Azasterol inhibition of delta 24-sterol methyltransferase in Saccharomyces cerevisiae. Biochemistry. 1984;23(16):3582–9.View ArticlePubMedGoogle Scholar
  31. Osumi T, Taketani S, Katsuki H, Kuhara T, Matsumoto I. Ergosterol biosynthesis in yeast. Pathways in the late stages and their variation under various conditions. J Biochem. 1978;83(3):681–91.PubMedGoogle Scholar
  32. Niedermeyer TH, Lindequist U, Mentel R, Gordes D, Schmidt E, Thurow K, Lalk M. Antiviral terpenoid constituents of Ganoderma pfeifferi. J Nat Prod. 2005;68(12):1728–31.View ArticlePubMedGoogle Scholar
  33. Giner JL, Zhao H. Detailed sterol compositions of two pathogenic rust fungi. Lipids. 2004;39(8):763–7.PubMedGoogle Scholar
  34. Mahto KK, Singh A, Khandelwal NK, Bhardwaj N, Jha J, Prasad R. An assessment of growth media enrichment on lipid metabolome and the concurrent phenotypic properties of Candida albicans. PLoS One. 2014;9(11):1–20.View ArticleGoogle Scholar
  35. Acuna-Johnson AP, Oehlschlager AC, Pierce AM, Pierce Jr HD, Czyzewska EK. Stereochemistry of yeast Δ24-sterol methyl transferase. Bioorg Med Chem. 1997;5(5):821–32.View ArticlePubMedGoogle Scholar
  36. Chapuis L, Malosse C, Corio-Costet MF. Sterol composition of the woody plant pathogenic fungus Eutypa lata. Phytochemistry. 1996;42(6):1599–601.View ArticleGoogle Scholar
  37. Neelakandan AK, Chamala S, Valliyodan B, Nes WD, Nguyen HT. Metabolic engineering of soybean affords improved phytosterol seed traits. Plant Biotechnol J. 2012;10(1):12–9.View ArticlePubMedGoogle Scholar
  38. Flannery AR, Renberg RL, Andrews NW. Pathways of iron acquisition and utilization in Leishmania. Curr Opin Microbiol. 2013;16(6):716–21.View ArticlePubMedGoogle Scholar
  39. Wilson ME, Lewis TS, Miller MA, McCormick ML, Britigan BE. Leishmania chagasi: uptake of iron bound to lactoferrin or transferrin requires an iron reductase. Exp Parasitol. 2002;100(3):196–207.View ArticlePubMedGoogle Scholar
  40. Wilson ME, Vorhies RW, Andersen KA, Britigan BE. Acquisition of iron from transferrin and lactoferrin by the protozoan Leishmania chagasi. Infect Immun. 1994;62(8):3262–9.PubMedPubMed CentralGoogle Scholar
  41. da Silva IA, Morato CI, Quixabeira VBL, Pereira LIA, Dorta ML, de Oliveira MAP, et al. In Vitro Metacyclogenesis of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis clinical field isolates, as evaluated by morphology, complement resistance, and infectivity to human macrophages. Bio Med Res Int. 2015;2015:15.Google Scholar
  42. Saraiva EM, Pinto-da-Silva LH, Wanderley JL, Bonomo AC, Barcinski MA, Moreira ME. Flow cytometric assessment of Leishmania spp. metacyclic differentiation: Validation by morphological features and specific markers. Exp Parasitol. 2005;110(1):39–47.View ArticlePubMedGoogle Scholar
  43. Bandyopadhyay P, Ghosh DK, De A, Ghosh KN, Chaudhuri PP, Das P, et al. Metacyclogenesis of Leishmania spp.: species-specific in vitro transformation, complement resistance, and cell surface carbohydrate and protein profiles. J Parasitol. 1991;77(3):411–6.Google Scholar
  44. Howard MK, Sayers G, Miles MA. Leishmania donovani metacyclic promastigotes: transformation in vitro, lectin agglutination, complement resistance, and infectivity. Exp Parasitol. 1987;64(2):147–56.View ArticlePubMedGoogle Scholar
  45. Nieves E, Pimenta PF. Development of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the sand fly Lutzomyia migonei (Diptera: Psychodidae). J Med Entomol. 2000;37(1):134–40.View ArticlePubMedGoogle Scholar
  46. Pinto-da-Silva LH, Camurate M, Costa KA, Oliveira SM, da Cunha-e-Silva NL, Saraiva EM. Leishmania (Viannia) braziliensis metacyclic promastigotes purified using Bauhinia purpurea lectin are complement resistant and highly infective for macrophages in vitro and hamsters in vivo. Int J Parasitol. 2002;32(11):1371–7.View ArticlePubMedGoogle Scholar
  47. Sturley SL. Conservation of eukaryotic sterol homeostasis: new insights from studies in budding yeast. Biochim Biophys Acta. 2000;1529(1-3):155–63.View ArticlePubMedGoogle Scholar
  48. Jacquier N, Schneiter R. Mechanisms of sterol uptake and transport in yeast. J Steroid Biochem Mol Biol. 2012;129(1-2):70–8.View ArticlePubMedGoogle Scholar
  49. Bates PA, Tetley L. Leishmania mexicana: induction of metacyclogenesis by cultivation of promastigotes at acidic pH. Exp Parasitol. 1993;76(4):412–23.View ArticlePubMedGoogle Scholar
  50. Serafim TD, Figueiredo AB, Costa PAC, Marques-da-Silva EA, Gonçalves R, de Moura SAL, et al. Leishmania metacyclogenesis is promoted in the absence of purines. PLoS Negl Trop Dis. 2012;6(9):e1833.Google Scholar
  51. Zakai HA, Chance ML, Bates PA. In vitro stimulation of metacyclogenesis in Leishmania braziliensis, L. donovani, L. major and L. mexicana. Parasitology. 1998;116(Pt 4):305–9.View ArticlePubMedGoogle Scholar
  52. Goluszko P, Nowicki B. Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cells. Infect Immun. 2005;73(12):7791–6.View ArticlePubMedPubMed CentralGoogle Scholar
  53. Ghosh J, Das S, Guha R, Ghosh D, Naskar K, Das A, et al. Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol. J Lipid Res. 2012;53(12):2560–72.Google Scholar
  54. Liberopoulos EN, Apostolou F, Gazi IF, Kostara C, Bairaktari ET, Tselepis AD, et al. Visceral leishmaniasis is associated with marked changes in serum lipid profile. Eur J Clin Invest. 2014;44(8):719–27.Google Scholar

Copyright

© Yao and Wilson. 2016

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Advertisement